COLBY CRILE: Open Payments
NPI 1649725326 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 76 payments from 16 companies in 2025. Trend: 2023 $2,204 · 2024 $1,337 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $298 |
| ABBVIE INC. | 11 | $222 |
| Galderma Laboratories, L.P. | 18 | $217 |
| Regeneron Healthcare Solutions, Inc. | 6 | $168 |
| Botanix SB Inc | 5 | $83 |
| LEO Pharma Inc. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Organon LLC | 3 | $48 |
| Amgen Inc. | 2 | $44 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, NEMLUVIO, SOFDRA, ADBRY, ILUMYA, RINVOQ.
Industry payments across FL — which companies pay providers there.
